Association between vaginal microbiota and the progression of ovarian cancer
Journal of Medical Virology · 2023-07 · 95 (7)
DOI: 10.1002/jmv.28898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 06.07.2023. Verfasst von Chanyuan Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Microbiota. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Ovarian cancers, especially high‐grade serous ovarian cancer (HGSOC), are one of the most lethal age‐independent gynecologic malignancies. Although pathogenic microorganisms have been demonstrated to participate in the pathogenesis of multiple types of tumors, their potential roles in the development of ovarian cancer remain unclear. To gain an insight into the microbiome‐associated pathogenesis of ovarian cancer and identify potential diagnostic biomarkers, we applied different techniques to analyse the microbiome and serum metabolome of different resources. We found that the vaginal microbiota in ovarian cancer mouse models was under dysbiosis, with altered metabolite configurations that may result from amino acid or lysophospholipid metabolic processes. Local therapeutic intervention with a broad spectrum of antibiotics was effective in reversing microbiota dysbiosis and suppressing carcinogenic progression. As the ovary is situated deeply in the pelvis, it is difficult to directly monitor the ovarian microbial community. Our findings provide alternative options for utilizing the vaginal bacteria as noninvasive biomarkers, such as Burkholderia (area under the curve = 0.8843, 95% confidence interval: 0.743–1.000), which supplement the current invasive diagnostic methods for monitoring ovarian cancer progression and contribute to the development of advanced microbe‐based diagnosis and adjuvant therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
- The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
- Cancer Center, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, China.
- College of Chemistry and Chemical Engineering, Hunan Provincial Key Laboratory of Micro & Nano Materials Interface Science, Central South University, Changsha, China.
Zitieren
APA
Li, C., Feng, Y., Yang, C., Wang, D., Zhang, D., Luo, X., Zhang, H., Huang, H., Zhang, H., Jiang, Y., Tan, W., & Liu, J. (2023). Association between vaginal microbiota and the progression of ovarian cancer. Journal of Medical Virology, 95(7). https://doi.org/10.1002/jmv.28898
Vancouver
Li C, Feng Y, Yang C, Wang D, Zhang D, Luo X, et al. Association between vaginal microbiota and the progression of ovarian cancer. Journal of Medical Virology. 2023;95(7). doi:10.1002/jmv.28898
BibTeX
@article{Li2023,
author = {Li, Chanyuan and Feng, Yanling and Yang, Cai and Wang, Dachi and Zhang, Dailiang and Luo, Xiaolin and Zhang, Han and Huang, He and Zhang, Hongyu and Jiang, Yanhui and Tan, Weihong and Liu, Jihong},
title = {Association between vaginal microbiota and the progression of ovarian cancer},
journal = {Journal of Medical Virology},
year = {2023},
volume = {95},
number = {7},
doi = {10.1002/jmv.28898}
}
EUVIMED